Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer

被引:68
|
作者
Zaravinos, Apostolos [1 ,2 ]
Roufas, Constantinos [1 ,3 ]
Nagara, Majdi [4 ]
de Lucas Moreno, Beatriz [1 ,5 ]
Oblovatskaya, Maria [1 ]
Efstathiades, Christodoulos [2 ,3 ]
Dimopoulos, Christos [2 ,3 ]
Ayiomamitis, Georgios D. [6 ]
机构
[1] European Univ Cyprus, Sch Sci, Dept Life Sci, CY-1516 Nicosia, Cyprus
[2] Ctr Risk & Decis Sci CERIDES, CY-2404 Nicosia, Cyprus
[3] European Univ Cyprus, Dept Comp Sci & Engn, CY-1516 Nicosia, Cyprus
[4] Aix Marseille Univ, Fac Med, INSERM, UMR S 1251,MMG, Marseille, France
[5] European Univ Madrid, Ctr Res Hlth & Life Sci, Madrid 28670, Spain
[6] Tzane Gen Hosp, Surg Dept 1, Piraeus 18536, Greece
关键词
Colorectal cancer; Cytolytic activity; Classically defined neoepitopes; Alternatively defined neoepitopes; Mutation burden; Immune checkpoints; Cancer drivers; CD8(+) T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; MISMATCH REPAIR DEFICIENCY; MICROSATELLITE INSTABILITY; ANTI-PD-L1; ANTIBODY; GENOMIC INSTABILITY; CLINICAL IMPACT; SOLID TUMORS; COLON; SURVIVAL;
D O I
10.1186/s13046-019-1372-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMicrosatellite unstable colorectal cancers (MSI+ CRCs) expressing PD-L1, respond to anti-PD-1 or anti-PD-L1 checkpoint blockade, whereas microsatellite-stable tumors do not respond the same. Our aim was to examine how the immune landscape relates to different aspects of the CRC's biology, including neoepitope burden.MethodsWe used TCGA data to stratify patients based on a cytolytic T-cell activity expression index and correlated immune cytolytic activity (CYT) with mutational, structural, and neoepitope features of each tumor sample. The expression of several immune checkpoints was verified in an independent cohort of 72 CRC patients, relative to their MSI status, using immunohistochemistry and RT-qPCR.ResultsCRC exhibits a range of intertumoral cytolytic T-cell activity, with lower cytolytic levels in the tumor, compared to the normal tissue. We separated CRC patients into CYT-high and CYT-low subgroups. High cytolytic activity correlated with increased mutational load in colon tumors, the count of MHC-I/-II classically defined and alternatively defined neoepitopes, high microsatellite instability and deregulated expression of several inhibitory immune checkpoints (VISTA, TIGIT, PD-1, IDO1, CTLA-4, and PD-L1, among others). Many immune checkpoint molecules (IDO1, LAG3, TIGIT, VISTA, PD-1, PD-L1 and CTLA-4) expressed significantly higher in MSI+ CRCs compared to MSS tumors. The expression of Treg markers was also significantly higher in CYT-high tumors. Both individual and simultaneous high levels of CTLA-4 and PD-L1 had a positive effect on the patients' overall survival. On the reverse, simultaneous low expression of both genes led to a significant shift towards negative effect. Assessed globally, CYT-low CRCs contained more recurrent somatic copy number alterations. PD-L1 protein was absent in most samples in the independent cohort and stained lowly in 33% of MSI CRCs. PD-L1+ CRCs stained moderately for CD8 and weakly for FOXP3. CYT-high colon tumors had higher TIL load, whereas CYT-high rectum tumors had higher TAN load compared to their CYT-low counterparts.ConclusionsOverall, we highlight the link between different genetic events and the immune microenvironment in CRC, taking into consideration the status of microsatellite instability. Our data provide further evidence that MSI+ and CYT-high tumors are better candidates for combinatorial checkpoint inhibition.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Expression of immune checkpoints proteins and their prognostic relevance in prostate cancer
    Hube-Magg, Claudia
    Schroeder, Cornelia
    Simon, Ronald
    Kluth, Martina
    Krech, Till
    Buscheck, Franziska
    Jacobsen, Frank
    Hoflmayer, Doris
    Budaus, Lars
    Huland, Hartwig
    Graefen, Markus
    Sauter, Guido
    Schlomm, Thorsten
    CANCER RESEARCH, 2017, 77
  • [32] Immune Checkpoints Expression in Small Cell Lung Cancer Lines
    Yu, Hui
    He, Yayi
    Rivard, Christopher
    Chan, Dan
    Gao, Dexiang
    Ellison, Kim
    Rozeboom, Leslie
    Suda, Kenichi
    Hirsch, Fred
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S281 - S281
  • [33] Expression of immune checkpoints in T cells of esophageal cancer patients
    Xie Jinhua
    Wang Ji
    Cheng Shouliang
    Zheng Liangfeng
    Ji Feiyue
    Yang Lin
    Zhang Yan
    Ji Haoming
    ONCOTARGET, 2016, 7 (39) : 63669 - 63678
  • [34] A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer
    Wang, Haoyu
    Liu, Jingchun
    Yang, Jiang
    Wang, Zhi
    Zhang, Zihui
    Peng, Jiaxin
    Wang, Ying
    Hong, Li
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer
    Pai, Sachin G.
    Carneiro, Benedito A.
    Chae, Young Kwang
    Costa, Ricardo L.
    Kalyan, Aparna
    Shah, Hiral A.
    Helenowski, Irene
    Rademaker, Alfred W.
    Mahalingam, Devalingam
    Giles, Francis J.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (05) : 858 - 866
  • [36] Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer
    Narayanan, Sumana
    Kawaguchi, Tsutomu
    Yan, Li
    Peng, Xuan
    Qi, Qianya
    Takabe, Kazuaki
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (08) : 2323 - 2331
  • [37] Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer
    Sumana Narayanan
    Tsutomu Kawaguchi
    Li Yan
    Xuan Peng
    Qianya Qi
    Kazuaki Takabe
    Annals of Surgical Oncology, 2018, 25 : 2323 - 2331
  • [38] FABP6 Expression Correlates with Immune Infiltration and Immunogenicity in Colorectal Cancer Cells
    Lian, Wenping
    Wang, Zhongquan
    Ma, Yajie
    Tong, Yalin
    Zhang, Xinyu
    Jin, Huifang
    Zhao, Shuai
    Yu, Ruijing
    Ju, Shaotan
    Zhang, Xinyun
    Guo, Xiaona
    Huang, Tao
    Ding, Xianfei
    Peng, Mengle
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [39] Correlation of exploration of immune profile and genomic with microsatellite stable/tumor mutational burden-low colorectal cancer.
    Abushukair, Hassan Mohammed
    Saeed, Azhar
    Sahin, Ibrahim Halil
    Saeed, Anwaar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 213 - 213
  • [40] DNA methylation of immune checkpoints in the peripheral blood of breast and colorectal cancer patients
    Elashi, Asma A.
    Nair, Varun Sasidharan
    Taha, Rowaida Z.
    Shaath, Hibah
    Elkord, Eyad
    ONCOIMMUNOLOGY, 2019, 8 (02):